South Korea Faces 15 Percent Pharma Tariffs Under Trump Section 232 Rule Starting July 2026 episode artwork

EPISODE · Apr 3, 2026 · 2 MIN

South Korea Faces 15 Percent Pharma Tariffs Under Trump Section 232 Rule Starting July 2026

from South Korea Tariff News and Tracker · host Inception Point AI

Welcome to South Korea Tariff News and Tracker, your essential update on how U.S. trade policies are reshaping global markets, with a sharp focus on South Korea. President Donald Trump just announced sweeping new tariffs on pharmaceuticals under Section 232, hitting patented drugs and ingredients with rates up to 100 percent to bolster U.S. national security and supply chains, according to a White House fact sheet released April 2, 2026. South Korea faces a targeted 15 percent tariff on these imports, alongside the European Union, Japan, and Switzerland, as confirmed by Politico reporting on the administration's details. The duties kick in 120 days for large firms and 180 days for smaller ones, effective around late July to September, per EY Tax News analysis, giving companies time to negotiate onshoring deals or most-favored-nation pricing to drop rates to zero or 20 percent. This move builds on Trump's broader tariff blitz, now marking one year since Liberation Day on April 2, 2025. The U.S. goods trade deficit shrank 24 percent from April 2025 through February 2026, with bilateral improvements against over 63 percent of trading partners, boasts a USTR press release. South Korean exporters, key in autos, steel, and semiconductors, navigate a landscape of 25 percent duties on automobiles and parts since May 2025, 25 percent on semiconductors since January 2026, and 50 percent on steel, per the Baker Botts Trump Tariff Tracker updated April 1. No South Korea-specific exemptions appear yet, unlike UK carve-outs. Pharma giants like those from South Korea could mitigate impacts by building U.S. facilities—already spurring $400 billion in commitments—or striking deals, as Pfizer and others have done. Critics like the Wall Street Journal highlight 90,000 jobs lost and mixed economic results, but the White House touts rebalanced trade and new deals with Japan and the EU that align standards. Listeners, stay ahead: South Korea's response could spark negotiations, echoing recent US-Japan pacts. Watch for updates as tariffs reshape supply chains. Thanks for tuning in, and don't forget to subscribe for the latest. This has been a Quiet Please production, for more check out quietplease.ai. For more check out https://www.quietperiodplease.com/ Avoid ths tariff fee's and check out these deals https://amzn.to/4iaM94Q This content was created in partnership and with the help of Artificial Intelligence AI.

Episode metadata supplied by the publisher feed · Published Apr 3, 2026

Embed this episode

NOW PLAYING

South Korea Faces 15 Percent Pharma Tariffs Under Trump Section 232 Rule Starting July 2026

0:00 2:30

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of South Korea Tariff News and Tracker?

This episode is 2 minutes long.

When was this South Korea Tariff News and Tracker episode published?

This episode was published on April 3, 2026.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this South Korea Tariff News and Tracker episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!